Although inflammation and activated NF-κB signaling have been associated with drug resistance in various cancers [11,12,13,19], only one paper reported the involvement of NLRP3 in the sensitivity of oral squamous cell carcinoma to 5-fluorouracil [20]. The gene discussed is NFKB1; the disease is cancer.